SEARCH CONTACT US

ACCESSIBILITY

24/7

Headlines

Israeli AI startup REplace raises $2.1M to accelerate clean energy deployment with site selection platform

Telegram's $1.745 billion bond sale severely oversubscribed

Empathy raises $72M Series C to streamline grief support and estate management

Full list of Israeli high-tech funding rounds in 2025

Buzz

Most popular

Daily

Weekly

1

Tenable acquires Sam Altman-backed Apex for over $105 million to boost AI security

2

Guardicore founders raise $32 million for new stealth cyber-AI startup

3

Check Point acquires Israeli cyber startup Veriti in deal estimated at over $100 million

4

eBay to shut down operations in Israel, over 200 employees to be laid off

5

Syte files for court protection after burning through $70 million in funding

Nucleai

6 stories about Nucleai

Spatial AI biomarker startup Nucleai raises $14 million led by Merck’s VC arm

Leveraging AI and machine learning, Nucleai analyzes pathology images and spatial data at the cellular and tissue levels. The proprietary technology extracts detailed patterns and features from medical images, offering insights into the tumor microenvironment, cellular morphology, and spatial relationships between different cell types

How have international stakeholders responded to Startup Nation since 7/10?

26.10.23|James Spiro

Nucleai helped its global customers and investors understand the magnitude of October 7 by comparing it to 9/11 in the U.S.

Nucleai raises $33 million for spatial biology drug development platform

22.03.22|Meir Orbach

The technology developed at the Israeli startup allows better prediction of the patient's response to specific oncological treatment, saves on the ongoing process of testing different drugs and improves the chances of the development of new cancer drugs

צוות Nucleai מימין לוטן חורב אלירון אמיר אבי ויידמן אלברט אכטרברג

The Israeli startup using spatial biology to provide better cancer treatment

02.01.22|Yafit Ovadia

Nucleai is looking at the way cells interplay and are interspersed within human tissue to develop precision medicine solutions

צוות Nucleai מימין לוטן חורב אלירון אמיר אבי ויידמן אלברט אכטרברג

AI cancer treatment startup Nucleai raises $6.5 million in series A round

07.07.20|Meir Orbach

Nucleai’s software uses computer vision and machine learning algorithms to predict the progress of cancerous tumors as well as the patient’s immune system response in order to determine the most efficient treatment

CTech’s Monday Israeli Tech News Roundup

Israel wants to lure U.S. scientists with $100 thousand grants. Barclays ends partnership with Ness Technologies